Garrison, Louis P.
University of Washington · Novartis Gene Therapies, Inc. (United States)
4 papers on CoChatORCID 0000-0002-9468-4989
Most cited papers
- Verified
Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations
Smith, S. M., Dworkin, R. H., Turk, D. C., McDermott, M. P., Eccleston, C., Farrar, J. T., Rowbotham, M. C., Bhagwagar, Z., Burke, L. B., Cowan, P., et al. (2020) · Pain
Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews
Cited by 194
- Verified
HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies
Coyle, D., Durand-Zaleski, I., Farrington, J., Garrison, L., Graf von der Schulenburg, J.-M., Greiner, W., Longworth, L., Meunier, A., Moutié, A.-S., Palmer, S., et al. (2020) · The European Journal of Health Economics
Health Systems, Economic Evaluations, Quality of LifePharmaceutical Economics and Policy
Cited by 71
- Verified
Gene therapy may not be as expensive as people think: challenges in assessing the value of single and short-term therapies
Garrison, L. P., Jiao, B., & Dabbous, O. (2021) · Journal of Managed Care & Specialty Pharmacy
Pharmaceutical Economics and PolicyHealth Systems, Economic Evaluations, Quality of Life
Cited by 41
- Verified
Acceptability of cervical cancer screening using visual inspection among women attending a childhood immunization clinic in Uganda
Li, M., Nyabigambo, A., Navvuga, P., Nuwamanya, E., Nuwasiima, A., Kaganda, P., Asiimwe, F. T., Vodicka, E., Mugisha, N. M., Mukose, A., et al. (2017) · Papillomavirus Research
Cervical Cancer and HPV ResearchWomen's cancer prevention and management
Cited by 22
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free